Literature DB >> 3977840

Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinases.

C E Smith, D A Johnson.   

Abstract

Bronchial leucocyte proteinase inhibitor (BLPI) is an 11 000 Mr protein found in human mucous secretions. This inhibitor apparently controls the serine proteinases elastase and cathepsin G, released from extravascular polymorphonuclear leucocytes. A simple, single-step chromatographic procedure for the isolation of BLPI based on its affinity for chymotrypsin was developed. The purified inhibitor was homogeneous by electrophoresis and gel filtration. Amino acid analyses were in close agreement with previous reports, and showed BLPI to be rich in proline and cystine, but lacking histidine. We have further characterized the role of BLPI with respect to human leucocyte elastase and cathepsin G by close examination of the kinetic parameters. Additionally, we have determined the kinetics of association (kon) and dissociation (koff) for BLPI with bovine trypsin and chymotrypsin. Equilibrium dissociation constants (Ki) of 1.87 X 10(-10) M, 4.18 X 10(-9) M, 8.28 X 10(-9) M and 2.63 X 10(-8) M were obtained for human leucocyte elastase, cathepsin G, bovine trypsin and chymotrypsin, respectively. These results are discussed with respect to BLPI's possible function in vivo and its role relative to other inhibitors in bronchial secretions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3977840      PMCID: PMC1144612          DOI: 10.1042/bj2250463

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Isolation and partial characterization of a low molecular weight acid stable protease inhibitor from human bronchial secretion.

Authors:  K Ohlsson; H Tegner; U Akesson
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1977-05

2.  Determination of the tryptophan content of proteins by ion exchange chromatography of alkaline hydrolysates.

Authors:  T E Hugli; S Moore
Journal:  J Biol Chem       Date:  1972-05-10       Impact factor: 5.157

3.  The synthesis and analytical use of a highly sensitive and convenient substrate of elastase.

Authors:  J Bieth; B Spiess; C G Wermuth
Journal:  Biochem Med       Date:  1974-12

4.  An improvement in the Hummel chymotrypsin assay.

Authors:  S H Kang; M S Fuchs
Journal:  Anal Biochem       Date:  1973-07       Impact factor: 3.365

5.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

6.  Trypsin-pancreatic trypsin inhibitor association. Dynamics of the interaction and role of disulfide bridges.

Authors:  J P Vincent; M Lazdunski
Journal:  Biochemistry       Date:  1972-08-01       Impact factor: 3.162

7.  Kinetics of the inhibition of leukocyte elastase by the bronchial inhibitor.

Authors:  F Gauthier; U Fryksmark; K Ohlsson; J G Bieth
Journal:  Biochim Biophys Acta       Date:  1982-01-18

8.  Human leukocyte granule elastase: rapid isolation and characterization.

Authors:  R J Baugh; J Travis
Journal:  Biochemistry       Date:  1976-02-24       Impact factor: 3.162

9.  Granulocyte collagenase, elastase and plasma protease inhibitors in purulent sputum.

Authors:  K Ohlsson; H Tegner
Journal:  Eur J Clin Invest       Date:  1975-06-12       Impact factor: 4.686

10.  Quantitative immunoelectrophoretic analysis of the plasma proteins in the sol phase of sputum from patients with chronic bronchitis.

Authors:  H C Ryley; T D Brogan
Journal:  J Clin Pathol       Date:  1973-11       Impact factor: 3.411

View more
  20 in total

1.  Directed evolution of a protein: selection of potent neutrophil elastase inhibitors displayed on M13 fusion phage.

Authors:  B L Roberts; W Markland; A C Ley; R B Kent; D W White; S K Guterman; R C Ladner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 2.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 3.  Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor.

Authors:  Stergios Doumas; Alexandros Kolokotronis; Panagiotis Stefanopoulos
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

Review 4.  The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core.

Authors:  J Schalkwijk; O Wiedow; S Hirose
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

5.  Detection of extracellular neutrophil elastase in hamster lungs after intratracheal instillation of E. coli lipopolysaccharide using a fluorogenic, elastase-specific, synthetic substrate.

Authors:  A Rudolphus; J Stolk; C van Twisk; C J van Noorden; J H Dijkman; J A Kramps
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

6.  Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.

Authors:  P Renesto; V Balloy; T Kamimura; K Masuda; A Imaizumi; M Chignard
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

7.  Inhibition of human pancreatic proteinases by mucus proteinase inhibitor, eglin c and aprotinin.

Authors:  D Belorgey; S Dirrig; M Amouric; C Figarella; J G Bieth
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

8.  Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase.

Authors:  R C Thompson; K Ohlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

9.  Secretory leukocyte protease inhibitor antagonizes paclitaxel in ovarian cancer cells.

Authors:  Nabila Rasool; William LaRochelle; Haihong Zhong; Gulshan Ara; Joshua Cohen; Elise C Kohn
Journal:  Clin Cancer Res       Date:  2010-01-12       Impact factor: 12.531

10.  Pharmacological activity of the C-terminal and N-terminal domains of secretory leukoprotease inhibitor in vitro.

Authors:  K Masuda; T Kamimura; K Watanabe; T Suga; M Kanesaki; A Takeuchi; A Imaizumi; Y Suzuki
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.